Invention Grant
- Patent Title: Chimeric inhibitor molecules of complement activation
- Patent Title (中): 嵌合抑制剂分子的补体激活
-
Application No.: US14585369Application Date: 2014-12-30
-
Publication No.: US09573984B2Publication Date: 2017-02-21
- Inventor: Peter Garred , Tina Hummelshoj Glue , Mikkel-Ole Skjodt
- Applicant: Rigshospitalet , Kobenhavns Universitet , Syddansk Universitet
- Applicant Address: DK Copenhagen O DK Copenhagen K DK Odense M.
- Assignee: RIGSHOSPITALET,KOBENHAVNS UNIVERSITET,SYDDANSK UNIVERSITET
- Current Assignee: RIGSHOSPITALET,KOBENHAVNS UNIVERSITET,SYDDANSK UNIVERSITET
- Current Assignee Address: DK Copenhagen O DK Copenhagen K DK Odense M.
- Agency: Womble Carlyle Sandridge & Rice LLP
- Priority: EP10155621 20100305
- Main IPC: A61K38/36
- IPC: A61K38/36 ; A61K38/00 ; A61P7/08 ; A61P43/00 ; A61K38/14 ; A61K35/14 ; A61K38/16 ; C07K1/00 ; C07K14/00 ; C07K16/00 ; C07K17/00 ; C12P21/08 ; C07K14/47 ; A61K38/17 ; A61K45/06
Abstract:
The present invention relates to novel chimeric molecules of ficolin-associated polypeptides, such as fusion polypeptides for the use in the treatment of conditions associated with inflammation, apoptosis, autoimmunity, coagulation, thrombotic or coagulopathic related diseases. The present invention further relates to nucleic acid molecules encoding such fusion polypeptides, vectors and host cells used in the production of the fusion polypeptides.
Public/Granted literature
- US20150210743A1 CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION Public/Granted day:2015-07-30
Information query
IPC分类:
